Eligible participant has to fullfill all of the following items | / / / / / / / |
Anyone with one of following items or more should be excluded: | / / / / / / / / / / |
- General information
- Medical history
- Physical examination
- Blood Routine Tests
- Urine Routine Test
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV/HCV/HIV/Syphilis Markers Test
- Renel Function Test
- D-dimer
- hCG Test
- Image Examinations
- Visual Analogue Scale
- Blood Gas Analysis
Date of signing the informed consent | 2024-1-31 |
Date of birth | 2005-04-08 yyyy-mm-dd |
Age | 18 Years |
Education background | Middle school
|
Occupation | Other
|
Other (Description) | 学生 |
1年前间断腰痛,1月前骶髂关节疼痛。 小时 |
|
久坐后 |
|
Number of pregnancy | 0 次 |
Number of delivery | 0 次 |
If has delivery history, select following items | |
partus maturus | -- 次 |
premature delivery | -- 次 |
abortion | -- 次 |
Last pregnancy | -- yyyy-mm-dd |
Average times of menstrual onset a year | 11 次/年 |
Average menstrual cycle | 31.5 天(days) |
Menarche time | 11 岁(years) |
The time of last Menstruation | 2024-01-21 年、月、日(yyyy-mm-dd) |
The time of menstrual onset before the last one | 不详 年、月、日(yyyy-mm-dd) |
斜视手术 |
|
2018 年/月/日(yyyy-mm-dd) |
|
Namy of the drug to be allergied | 无 |
Vulva | Normal
|
Description in detail for abnormal | -- |
Vagina | Not examined
|
Description in detail for abnormal | -- |
Uterine neck | Not examined
|
Description in detail for abnormal | -- |
Corpus uteri | Not examined
|
Description in detail for abnormal | --- |
Adnexa uteri | |
Left side | Normal
|
Description in detail for abnormal | -- |
Right side | Abnormal
|
Description in detail for abnormal | 7*8*8cm包块 |
Weight | 72 kg |
Hight | 1670 mm |
Systolic pressure (SP) | 129 mmHg |
Diastolic pressure | 87 mmHg |
Temperature | 36.2 degree Celsius |
Pulse rate | 100 次/分 |
Breath frequency | 23 次/分 |
Doctor signature | 刘义彬 |
Date | 2024-1-31 yyyy-mm-dd |
WBC | 6.80 ×109 /L |
NEUT% | 52.40 % |
LY% | 37.00 % |
MONO% | 5.46 % |
RBC | 3.90 ×10^12 /L |
HGB | 116 g/L |
PLT | 291 ×10^9 /L |
Researcher signature | 刘义彬 |
Date | 2024-2-1 yyyy-mm-dd |
Acidity and allkalinity | Acidity
|
pH value | 6.5 |
Urine protein | |
Urine red cell | Negative
|
Urine WBC | Positive+++
|
Urine glucos | Negative
|
Urine Bilirubin | Negative
|
Urine HCG | Negative
|
KET | |
SG | 1.017 |
UBG | Negative
|
NIT | Negative
|
Date of test | 2024-2-1 yyyy-mm-dd |
Date of test | 2024-2-1 yyyy-mm-dd |
K | 4.39 mmol/L |
Na | 141.8 mmol/L |
Cl | 105.5 mmol/L |
Ca | 2.23 mmol/L |
P | 1.35 mmol/L |
Date of examination | 2024-2-1 yyyy-mm-dd |
Prothrombin time | 12.5 秒 |
Thrombin time (TT) | 15.9 秒 |
Activated partial thromboplastin time (APTT) | 32.5 秒 |
Fibrinogen (FIB) | 2.27 g/L |
ALT | 11.9 IU/L |
AST | 16.2 IU/L |
GGT | 12.0 U/L |
Serum bilirubin | 12.40 μmol/L |
Indirect bilirubin | 8.70 umol/L |
Direct bilirubin | 3.70 umol/L |
Serum albumin | 41.5 g/L |
Serum globulin | 20.9 g/L |
Serum total protein | 62.4 g/L |
Date of test | 2024-2-1 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-1 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-1 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-1 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-1 yyyy-mm-dd |
SCr | 46.0 μmol/L |
Blood urea | 3.60 mmol/L |
Blood uric acid | 260.0 μmol/L |
Date of test | 2024-2-1 yyyy-mm-dd |
D-dimer value | 0.05 ug/mL |
Date of test | 2024-2-1 |
Urine pregnancy test | Not tested
|
Blood HCG concentration | -- mIU/mL |
Date of test | -- yyyy-mm-dd |
Size of the ulcer | 5.66*4.75*4.41 cm*cm |
Uterine echo distribution | Not even
|
Endometrial thickness | 1.16 mm |
Left ovary size | 2.68*2.21 cm ×cm |
Shape of Left ovary | Normal
|
Size of the Ovarian cyst | -- |
Right ovary size | 7.73*6.02 cm ×cm |
Shape of right ovary | Ovarian cyst
|
Size of Ovarian cyst | 7.30 |
Description of other abnormal findings | -- |
Diagnosis of the Ultrasound B | 右卵巢囊肿 |
Doctor signature | 刘义彬 |
Date of examination | 2024-1-20 yyyy-mm-dd |
Pain Visual Analogue Score | Occasionally very slight pain
|
PH | 7.413 |
PCO2 | 39.9 mmHg |
P02 | 327.5 mmHg |
SO2 | 98.4 % |
HCO3 | 24.9 mmol/l |
SBE | 0.3 mmol/l |
LAC | 0.88 mmol/L |
Date of examination | 2024-2-2 (yyyy-mm-dd) |
右卵巢 |
|
7cm cm |
|
-- ° |
|
/ | |
刘义彬 |
|
2024-2-2 |
D-dimer value | 0.13 ug/mL |
Date of test | 2024-2-3 |
Body temperature | 37.2 ℃ |
Systolic pressure (SP) | 109 mmHg |
Diastolic pressure (DP) | 67 mmHg |
Heart Rate, HR | 100 次/分 |
Pulse | 100 次/秒 |
WBC | 11.20 ×109 /L |
NEUT% | 77.11 % |
LY% | 14.85 % |
MONO% | 7.71 % |
RBC | 3.68 ×10^12 /L |
HGB | 109 g/L |
PLT | 276 ×10^9 /L |
Date | 2024-2-3 yyyy-mm-dd |
/ | |
Pain Visual Analogue Score | Occasionally very slight pain
|
sample collection | Collected
|
Volume | 1 ml |
Time of collection | 2024-2-1 2024-2-3 yyyy-mm-dd-hh-min. |
Label Number of the sample | 2562016 |
Date received at DCC | - yyyymmdd |
Report type | |
Name of this event | -- |
SAE start date | -- yyyymmdd |
SAE stop date | -- yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below | -- |
Name of the recorder | -- |
Data | -- yyyymmdd |
Site Investigator’s signature | - |
Data | - yyyymmdd |